Status:
COMPLETED
Effects of a Lifestyle Intervention on Body Mass Index in Patients With Bipolar Disorder
Lead Sponsor:
University of Zurich
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Patients with bipolar disorder are at increased risk of weight gain, which in turn, increases the risk for somatic disease and non-adherence to maintenance therapy. Therefore, interventions addressing...
Eligibility Criteria
Inclusion
- Adults between 18 and 70 years of age were considered for inclusion if they:
- fulfilled the diagnostic criteria for bipolar disorder according to DSM-IV-TR,27;
- were on treatment with medication for at least three months with one of the following substances: lithium, valproic acid carbamazepine, oxcarbazepine, olanzapine, quetiapine, risperidone, amisulpride; and
- were not underweight (BMI \> 20 kg/m2).
Exclusion
- Pregnancy
- Actual breast feeding
- A diagnosis of anorexia nervosa or bulimia nervosa
- Diabetes type I or II or another serious physical disease
- Use of substances that reduce weight (e.g., topiramate, lamotrigine as mood stabilizer in monotherapy)
- Participants with comorbidity of acute psychosis, drug addiction, personality disorder, suicidal tendencies or a current severe manic or depressive episode were excluded only if attending the program was not possible due to the respective disorder
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00980863
Start Date
March 1 2005
End Date
August 1 2006
Last Update
September 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanatorium Kilchberg
Zurich, Switzerland